Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease
- PMID: 17563247
- DOI: 10.1586/14737175.7.6.637
Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease
Abstract
Botulinum toxins are an effective treatment modality for a growing number of neurologic conditions. Although there has been varied interest and success in their use, they have been studied for a variety of conditions associated with Parkinson's disease. Conditions reviewed in this paper include hand and jaw tremor, dystonia, blepharospasm and apraxia of eyelid opening, bruxism, camptocormia, freezing of gait, sialorrhea and constipation. We will make comments when applicable on our unique experience with botulinum toxin in these conditions. Other conditions associated with Parkinson's disease, which will not be reviewed here, but may benefit from botulinum toxin treatment include anterocollis (also known as dropped head syndrome), hyperhidrosis, seborrhea and overactive bladder.
Similar articles
-
Disease-oriented approach to botulinum toxin use.Toxicon. 2009 Oct;54(5):614-23. doi: 10.1016/j.toxicon.2008.11.013. Epub 2008 Dec 6. Toxicon. 2009. PMID: 19073203 Review.
-
Use of botulinum toxin in Parkinson's disease.Parkinsonism Relat Disord. 2019 Feb;59:57-64. doi: 10.1016/j.parkreldis.2018.12.002. Epub 2018 Dec 11. Parkinsonism Relat Disord. 2019. PMID: 30579818 Review.
-
An update on the use of botulinum toxin therapy in Parkinson's disease.Curr Neurol Neurosci Rep. 2015 Jan;15(1):511. doi: 10.1007/s11910-014-0511-3. Curr Neurol Neurosci Rep. 2015. PMID: 25407133 Review.
-
Botulinum toxin treatment of secretory disorders.Mov Disord. 2004 Mar;19 Suppl 8:S137-41. doi: 10.1002/mds.20067. Mov Disord. 2004. PMID: 15027066 Review.
-
Botulinum toxins: pharmacology and its current therapeutic evidence for use.Neurol India. 2003 Dec;51(4):455-60. Neurol India. 2003. PMID: 14742921 Review.
Cited by
-
Temporal characteristics of botulinum neurotoxin therapy.Expert Rev Neurother. 2010 Jan;10(1):93-103. doi: 10.1586/ern.09.134. Expert Rev Neurother. 2010. PMID: 20021324 Free PMC article. Review.
-
Efficacy of botulinum toxin type a for treating chronic low back pain.Anesth Pain Med. 2011 Fall;1(2):77-80. doi: 10.5812/kowsar.22287523.1845. Epub 2011 Sep 26. Anesth Pain Med. 2011. PMID: 25729661 Free PMC article.
-
Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.Front Syst Neurosci. 2011 Jul 4;5:49. doi: 10.3389/fnsys.2011.00049. eCollection 2011. Front Syst Neurosci. 2011. PMID: 21772815 Free PMC article.
-
Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.Toxins (Basel). 2021 Jul 20;13(7):505. doi: 10.3390/toxins13070505. Toxins (Basel). 2021. PMID: 34357977 Free PMC article.
-
Use of botulinum toxin for movement disorders.Drugs Context. 2019 Jun 18;8:212586. doi: 10.7573/dic.212586. eCollection 2019. Drugs Context. 2019. PMID: 31258617 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical